Personalized medicine for glioblastoma: current challenges and future opportunities. [electronic resource]
Producer: 20130815Description: 358-67 p. digitalISSN:- 1875-5666
- Cell Cycle -- genetics
- Cell Proliferation -- drug effects
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Genetic Variation
- Glioblastoma -- genetics
- Humans
- Isocitrate Dehydrogenase -- genetics
- MicroRNAs -- genetics
- Precision Medicine
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Signal Transduction
- Tumor Microenvironment
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.